Crossmark

Study protocol: a multi-center, double-blind, randomized, 6-month, placebo-controlled trial to investigate the effect of supplementing hormone therapy FET cycles with Gushen’antai pills on the outcomes of in vitro fertilization

Crossref DOI link: https://doi.org/10.1186/s13063-021-05614-w

Published Online: 2021-09-26

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Ying-jie

Cao, Xian-ling

Ma, Ting

Song, Jing-yan

Yu, Ling-yu

Yu, Yang-yang

Zhao, Jian-Yun

Sun, Zhen-Gao https://orcid.org/0000-0002-9723-1213
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81874016)
License Information

Text and Data Mining valid from 2021-09-26

Version of Record valid from 2021-09-26
More Information

Article History

Received: 15 November 2020

Accepted: 13 September 2021

First Online: 26 September 2021

Declarations

:

: Informed consent was obtained from all patients, and protocols were approved by the Reproductive Medicine Ethics Committees of the Affiliated Hospital of Shandong University of TCM before any study procedures were done.

: All authors agree to publish.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below